AMPYRA for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where AMPYRA was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for AMPYRA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 711 | 18.0% | 2 | 16 |
| Gait disturbance | 518 | 13.1% | 4 | 21 |
| Dizziness | 354 | 9.0% | 0 | 6 |
| Insomnia | 313 | 7.9% | 0 | 3 |
| Balance disorder | 262 | 6.6% | 1 | 10 |
| Headache | 247 | 6.2% | 1 | 8 |
| Nausea | 233 | 5.9% | 0 | 7 |
| Fall | 208 | 5.3% | 3 | 31 |
| Fatigue | 185 | 4.7% | 4 | 5 |
| Asthenia | 179 | 4.5% | 2 | 18 |
| Inappropriate schedule of drug administration | 178 | 4.5% | 3 | 9 |
| Urinary tract infection | 166 | 4.2% | 5 | 30 |
| Drug dose omission | 162 | 4.1% | 0 | 14 |
| Multiple sclerosis relapse | 159 | 4.0% | 3 | 49 |
| Back pain | 145 | 3.7% | 1 | 13 |
Other Indications for AMPYRA
Product used for unknown indication (1,872)
Gait disturbance (1,453)
Multiple sclerosis (646)
Balance disorder (40)
Muscular weakness (16)
Asthenia (15)
Fatigue (15)
Ataxia (11)
Muscle spasticity (7)
Peroneal nerve palsy (6)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)